Press Release
Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024
September 15, 2024
Read More at Our Investor SiteWe do it by making a difference in the lives of our patients. Stay current with the latest news, information and events at Lantheus. Please visit our investor site for a complete list of recent and archived press releases. Follow us on LinkedIn and X for social media updates.
For media resources, including images, logos, videos, and more, browse our media library.
Press Release
September 15, 2024
Read More at Our Investor SitePress Release
September 5, 2024
Read More at Our Investor SitePress Release
August 28, 2024
Read More at Our Investor Site